Skip to main content

Navigation group

Type at least 3 characters
146 articles

Articles

Original Research

Published on 07 Apr 2022

Ki67 Immunohistochemical Expression Level ≥70%, Bulky Presentation ≥7.5 cm, Meningeal Lymphomatosis, and Interim PET ΔSUVmax After 4 Treatment Cycles <71% as Parts of a Practical Scoring System to Predict Progression-Free Survival and Overall Survival in Diffuse Large B-Cell Lymphoma

in PET and SPECT

  • Vincent Rebière
  • Meriem Maajem
  • Ronan Le Calloch
  • Leela Raj
  • Anne-Sophie Le Bris
  • Mohamed Malou
  • François Salmon
  • Isabelle Quintin-Roué
  • Adrian Tempescul
  • David Bourhis
Ki67 Immunohistochemical Expression Level ≥70%, Bulky Presentation ≥7.5 cm, Meningeal Lymphomatosis, and Interim PET ΔSUVmax After 4 Treatment Cycles <71% as Parts of a Practical Scoring System to Predict Progression-Free Survival and Overall Survival in Diffuse Large B-Cell Lymphoma
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.829138
  • 1,941 views
  • 2 citations